Heterozygous Familial Hypercholesterolemia-Reference-Cited by-同舟云学术

Heterozygous Familial Hypercholesterolemia

Published:2016-04-05 Issue:14 Volume:133 Page:
ISSN:0009-7322
Container-title:Circulation
language:en
Short-container-title:Circulation

Author:

Onorato Angela¹,Sturm Amy C.¹

Affiliation:

1. From The Ohio State University College of Medicine (A.O.), Division of Human Genetics (A.C.S.), and Dorothy M. Davis Heart and Lung Research Institute (A.C.S.), Ohio State University Wexner Medical Center.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Link

https://www.ahajournals.org/doi/pdf/10.1161/CIRCULATIONAHA.115.020701

Reference5 articles.

1. The Agenda for Familial Hypercholesterolemia

2. Familial Hypercholesterolemia: Screening, diagnosis and management of pediatric and adult patients

3. Familial Hypercholesterolemia and the 2013 American College of Cardiology/American Heart Association Guidelines: Myths, Oversimplification, and Misinterpretation Versus Facts

4. The Severe Hypercholesterolemia Phenotype

5. Integrated guidance on the care of familial hypercholesterolaemia from the International FH Foundation

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Is Family History for the Management of Cardiovascular Health in Youth Still Relevant in Clinical Practice?;Current Atherosclerosis Reports;2024-08-27

2. Targeting systemic inflammation in metabolic disorders. A therapeutic candidate for the prevention of cardiovascular diseases?;Pharmacological Research;2024-02

3. Identification and functional characterization of two rare LDLR stop gain variants (p.c231*and p.R744*) in Saudi familial hypercholesterolemia patients;PANMINERVA MED;2023

4. Evolution of More Aggressive LDL-Cholesterol Targets and Therapies for Cardiovascular Disease Prevention;Journal of Clinical Medicine;2023-11-30

5. Metabolic systems approaches update molecular insights of clinical phenotypes and cardiovascular risk in patients with homozygous familial hypercholesterolemia;BMC Medicine;2023-07-27